Search clinical trials for: Acalabrutinib Treatment A

Total 21147 results

University of Aarhus

Active, not recruiting

Weight-loss Treatment Program in Children and Adolescents

Weight Loss | Childhood Obesity | Health Behavior | Motivation
First Affiliated Hospital Xi'an Jiaotong University

Completed

Perioperative Eosinophils Their Recovery in Type A Acute Aortic Dissection Prognosis

Acute Aortic Dissection

China
Acerta Pharma BV

Active, not recruiting

A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United Kingdom, Poland
University of Miami
National Institute of Mental Health (NIMH); University of Connecticut

Completed

Community Study of Outcome Monitoring for Emotional Disorders in Teens (COMET)

Depression | Anxiety

United States
Institut Claudius Regaud

Completed

Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE). (MOTIVATE)

Solid Tumor

France
University Hospital, Caen

Unknown

Mathematical Models Derived Indices for the Selection and Planning of a Specific Optimal Treatment to the Patient in Heart Failure (VP2HF)

Heart Failure
Rheumatology Therapeutics Medical Center
Kochan Institute for Healing Arts Research

Unknown

Safety and Efficacy Study of Bee Venom to Treat Knee Osteoarthritis

Persons With Mild to Moderate Knee Osteoarthritis

United States
AstraZeneca

Completed

A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects

Heart Failure

United Kingdom
AstraZeneca

Completed

A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants

Healthy Participants | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)

United States
Acerta Pharma BV

Completed

A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult Participants

Healthy Volunteers

United States
Supernus Pharmaceuticals, Inc.

Completed

Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult Subjects

Healthy Volunteer

Australia
NovoBliss Research Pvt Ltd

Completed

Process Validation in Dermatology: Assessing Methods for UV Exposure (Artificial Source vs. Sunlight) and Efficacy Evaluation of Anti-Tanning Agents

Skin Pigmentation

India
University of Oulu

Unknown

The Effect of Timing on Orthodontic Treatment

Malocclusion, Angle Class II
Janssen Research & Development, LLC

Completed

A Study to Assess the Bioequivalence of 2 Fixed Dose Combination Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

Healthy

United States
University Hospital, Caen

Completed

HEMOTOL: Efficacy and Safety of Hemodialysis On-line Monitoring Devices on Hemodynamic Stability in Intensive Care Unit (HEMOTOL)

Hemodialysis

France
University Hospital, Basel, Switzerland

Recruiting

Improving Emergency Management of Status Epilepticus (SESIM)

Status Epilepticus

Switzerland
University of Western Ontario, Canada
Canadian Institutes of Health Research (CIHR); Children's Hospital of Eastern...

Completed

Parenting Matters: Helping Parents With Young Children

Child Behavior | Behavior Problems | Sleep Problems

Canada
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute; Carolina Institute...

Completed

Social Cognition and Interaction Training for Autism (SCIT-A)

Autism | Social Behavior

United States
University of Washington
National Institute of Mental Health (NIMH)

Completed

Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder

Bipolar Disorder

United States
University of California, Los Angeles
University of Colorado, Boulder

Completed

Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder

Bipolar Disorder

United States
AstraZeneca
Parexel

Completed

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Chronic Obstructive Pulmonary Disease (COPD)

United States
Beijing Anzhen Hospital

Not yet recruiting

The National Program for the Improvement of Management of Fetal Congenital Heart Disease in China

Fetal Echocardiography | Congenital Heart Disease in Pregnancy | Prenatal Diagnosis
metaMe Health

Completed

Efficacy and Safety of IBS Digital Behavioral Treatment (EASITx)

Irritable Bowel Syndrome

United States
AstraZeneca
Merck Sharp & Dohme LLC; Iqvia Pty Ltd

Completed

A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours. (IVIVC)

Malignant Solid Tumor

Belgium
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma

Osteosarcoma
China-Japan Friendship Hospital

Active, not recruiting

Construction of a National Diagnosis and Treatment Quality Control Platform for Major Respiratory Diseases

Quality Control

China
Theranica

Completed

Relief of Migraine Pain Through Electro Stimulation

Migraine Headache

Israel
University of Chicago

Withdrawn

Single vs Multi-fraction SRS Patients on Immunotherapy (MIGRAINE)

Brain Cancer | Brain Metastases

United States
Cerevel Therapeutics, LLC

Recruiting

A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants

Healthy Participants

United States
Institute of Cardiology, Warsaw, Poland
Medical Research Agency, Poland

Recruiting

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients (SAFE LAAC CKD)

Atrial Fibrillation

Poland
MingSight Pharmaceuticals, Inc

Recruiting

A Study Of The Selective PKC-β Inhibitor MS- 553

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Aggressive Lymphoma

United States
Pfizer

Completed

A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants

Healthy

United States
Ardelyx

Completed

To Assess the Effect of AZD1722 on the Pharmacokinetics of Cefadroxil in Healthy Volunteers

Healthy Volunteers

United States
Ferring Pharmaceuticals

Completed

Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease (PROGNOS)

Crohn's Disease

Germany
Tata Memorial Centre

Completed

A Survey to Assess Knowledge, Attitudes & Practices in Surgeons With Regards to Breast Conservation Surgery & Mastectomy

Health Knowledge, Attitudes, Practice | Health Personnel Attitude

India
Abbott Medical Devices

Completed

Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapies in Primary Prevention Patients (DECREASE)

Cardiac Death

Germany
Washington University School of Medicine
AstraZeneca

Recruiting

Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma

United States
Memorial Sloan Kettering Cancer Center
AstraZeneca; Genentech, Inc.

Active, not recruiting

A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Acerta Pharma BV
AstraZeneca

Active, not recruiting

Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL (AMPLIFY)

Chronic Lymphocytic Leukemia

United States, Spain, Canada, Italy, Taiwan, Russian Federation, Turkey, Germany, Korea, Republic of, Brazil, Hungary, Poland, China, Sweden, Bulgaria, Israel, United Kingdom, Australia, Saudi Arabia, Austria, France, Czechia, South... and more
Université du Québec à Trois-Rivières
Université de Sherbrooke; Laval University; Université de Montréal; Université...

Recruiting

Integrative Couple Treatment for Gambling/Substance Use Disorder

Substance Use Disorders | Gambling Disorder

Canada
University Health Network, Toronto

Active, not recruiting

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

Canada
AstraZeneca

Recruiting

Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.

Heathy Participants

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate Bioequivalence and Adhesion of a Transdermal Contraceptive Patch Manufactured With Newly Sourced Adhesive Components and Currently Marketed EVRA in Healthy Adult Women

Healthy

Belgium
Foundation for Liver Research

Completed

PEG-IFN in HBV Patients With Incomplete Response to NA (PADD)

Chronic Hepatitis B

Netherlands
Basque Health Service
Carlos III Health Institute; Preventive Services and Health Promotion Research... and other collaborators

Unknown

Exercise for Patients With Heart Failure in Primary Care: the EFICAR (EFICAR)

Heart Failure

Spain
AstraZeneca
Parexel

Not yet recruiting

A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) Hydrofluoroolefin (HFO) With a Spacer (Treatment B), BGF MDI Hydrofluoroalkane (HFA) With a Spacer (Treatment A), as Well as BGF MDI HFO Without a Spacer (Treatment C).

Healthy
Aprea Therapeutics

Terminated

APR-246 in Combination With Acalabrutinib or Venetoclax Based Therapy in Subjects With R/R Non Hodgkin Lymphomas (NHL) (R/R)

Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted

Healthy

Belgium
AstraZeneca

Not yet recruiting

A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) Hydrofluoroolefin (HFO) With a Spacer (Treatment B), BGF MDI Hydrofluoroalkane (HFA) With a Spacer (Treatment A), as Well as BGF MDI HFO Without a Spacer (Treatment C).

Chronic Obstructive Pulmonary Disease

Germany, United Kingdom
Salmaniya Medical Complex

Recruiting

Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19

Covid19

Bahrain

3

Subscribe